Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details)

v3.22.2
SCHEDULE OF REVENUES, OPERATING EXPENSES AND OPERATING INCOME (LOSS) BY REPORTABLE SEGMENT (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Segment Reporting Information [Line Items]        
NET REVENUE $ 37,228 $ 34,065 $ 72,569 $ 63,834
Direct operating costs 21,787 20,534 44,460 38,595
Selling and marketing 2,426 2,204 4,810 4,094
General and administrative 6,394 6,269 11,979 11,893
Research and development 1,098 1,813 2,083 3,839
Change in contingent consideration (630) (1,230)
Depreciation and amortization 2,936 3,128 5,876 5,959
Net loss on lease termination, impairment and unoccupied lease charges 463 223 621 1,241
Total operating expenses 34,474 34,171 68,599 65,621
OPERATING INCOME (LOSS) 2,754 (106) 3,970 (1,787)
Healthcare IT [Member]        
Segment Reporting Information [Line Items]        
NET REVENUE 34,029 31,085 66,182 58,119
Direct operating costs 19,285 18,161 39,296 34,149
Selling and marketing 2,421 2,197 4,797 4,079
General and administrative 3,582 3,411 6,982 6,839
Research and development 1,098 1,813 2,083 3,839
Change in contingent consideration (630)   (1,230)  
Depreciation and amortization 2,847 3,043 5,699 5,792
Net loss on lease termination, impairment and unoccupied lease charges 463 223 621 1,241
Total operating expenses 29,066 28,848 58,248 55,939
OPERATING INCOME (LOSS) 4,963 2,237 7,934 2,180
Medical Practice Management [Member]        
Segment Reporting Information [Line Items]        
NET REVENUE 3,199 2,980 6,387 5,715
Direct operating costs 2,502 2,373 5,164 4,446
Selling and marketing 5 7 13 15
General and administrative 420 497 857 1,016
Research and development
Change in contingent consideration    
Depreciation and amortization 89 85 177 167
Net loss on lease termination, impairment and unoccupied lease charges
Total operating expenses 3,016 2,962 6,211 5,644
OPERATING INCOME (LOSS) 183 18 176 71
Unallocated Corporate Expenses [Member]        
Segment Reporting Information [Line Items]        
NET REVENUE
Direct operating costs
Selling and marketing
General and administrative 2,392 2,361 4,140 4,038
Research and development
Change in contingent consideration    
Depreciation and amortization
Net loss on lease termination, impairment and unoccupied lease charges
Total operating expenses 2,392 2,361 4,140 4,038
OPERATING INCOME (LOSS) $ (2,392) $ (2,361) $ (4,140) $ (4,038)